In an effort to give you the best possible service, we would be grateful if you could take a few minutes of your time to answer a few questions.
My Saved Results
Join Our Mailing List
Home / Clinical Trials / Find Clinical Trials / A Phase 1 Dose-Escalation and Pharmacokinetic Study of TG02 Citrate...
I'm a new user and need a user account
Forgot your password?
This is a multicenter, open-label, dose escalation study. The primary objective is to determine the highest dose of TG02 citrate that can safely be given to patients with different types of hematological malignancy.
Winship Cancer Institute of Emory University1365 Clifton Road NEBuilding CAtlanta, GA 30322404-778-5180winshipcancer.emory.edu